1. Product Overview
1.1.
Market
Definition
1.2.
Scope
of the Market
1.2.1.
Markets
Covered
1.2.2.
Years
Considered for Study
1.2.3.
Key
Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1.
Overview
of the Market
3.2.
Overview
of Key Market Segmentations
3.3.
Overview
of Key Market Players
3.4.
Overview
of Key Regions/Countries
3.5.
Overview
of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global
Artificial Cornea and Corneal Implants Market Outlook
5.1. Market Size & Forecast
5.1.1.
By
Value
5.2. Market Share & Forecast
5.2.1.
By Type
(Human Cornea and Artificial Cornea)
5.2.2.
By Transplant
Type (Penetrating Keratoplasty and Endothelial Keratoplasty)
5.2.3.
By
Disease Indication (Fuchs’ Dystrophy, Keratoconus, Fungal Keratitis, Others)
5.2.4.
By End
User (Hospitals, Ambulatory Care Centers, Others)
5.2.5.
By
Region
5.2.6.
By
Company (2023)
5.3. Market Map
6.
North
America Artificial Cornea and Corneal Implants Market Outlook
6.1. Market Size & Forecast
6.1.1.
By
Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2.
By Transplant
Type
6.2.3.
By
Disease Indication
6.2.4.
By End
User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1.
United
States Artificial Cornea and Corneal Implants Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By
Type
6.3.1.2.2.
By
Transplant Type
6.3.1.2.3.
By
Disease Indication
6.3.1.2.4.
By
End User
6.3.2.
Canada
Artificial Cornea and Corneal Implants Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By
Type
6.3.2.2.2.
By
Transplant Type
6.3.2.2.3.
By
Disease Indication
6.3.2.2.4.
By
End User
6.3.3.
Mexico
Artificial Cornea and Corneal Implants Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By
Type
6.3.3.2.2.
By
Transplant Type
6.3.3.2.3.
By
Disease Indication
6.3.3.2.4.
By
End User
7.
Europe
Artificial Cornea and Corneal Implants Market Outlook
7.1. Market Size & Forecast
7.1.1.
By
Value
7.2. Market Share & Forecast
7.2.1.
By
Type
7.2.2.
By
Transplant Type
7.2.3.
By
Disease Indication
7.2.4.
By
End User
7.2.5.
By
Country
7.3. Europe: Country Analysis
7.3.1.
Germany
Artificial Cornea and Corneal Implants Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By
Type
7.3.1.2.2.
By
Transplant Type
7.3.1.2.3.
By
Disease Indication
7.3.1.2.4.
By
End User
7.3.2.
United
Kingdom Artificial Cornea and Corneal Implants Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By
Type
7.3.2.2.2.
By
Transplant Type
7.3.2.2.3.
By
Disease Indication
7.3.2.2.4.
By
End User
7.3.3.
Italy
Artificial Cornea and Corneal Implants Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By
Type
7.3.3.2.2.
By
Transplant Type
7.3.3.2.3.
By
Disease Indication
7.3.3.2.4.
By
End User
7.3.4.
France
Artificial Cornea and Corneal Implants Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By
Type
7.3.4.2.2.
By
Transplant Type
7.3.4.2.3.
By
Disease Indication
7.3.4.2.4.
By
End User
7.3.5.
Spain
Artificial Cornea and Corneal Implants Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By
Type
7.3.5.2.2.
By
Transplant Type
7.3.5.2.3.
By
Disease Indication
7.3.5.2.4.
By
End User
8.
Asia-Pacific
Artificial Cornea and Corneal Implants Market Outlook
8.1. Market Size & Forecast
8.1.1.
By
Value
8.2. Market Share & Forecast
8.2.1.
By
Type
8.2.2.
By
Transplant Type
8.2.3.
By
Disease Indication
8.2.4.
By
End User
8.2.5.
By
Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China
Artificial Cornea and Corneal Implants Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By
Type
8.3.1.2.2.
By
Transplant Type
8.3.1.2.3.
By
Disease Indication
8.3.1.2.4.
By
End User
8.3.2.
India
Artificial Cornea and Corneal Implants Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By
Type
8.3.2.2.2.
By
Transplant Type
8.3.2.2.3.
By
Disease Indication
8.3.2.2.4.
By
End User
8.3.3.
Japan
Artificial Cornea and Corneal Implants Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By
Type
8.3.3.2.2.
By
Transplant Type
8.3.3.2.3.
By
Disease Indication
8.3.3.2.4.
By
End User
8.3.4.
South
Korea Artificial Cornea and Corneal Implants Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By
Type
8.3.4.2.2.
By
Transplant Type
8.3.4.2.3.
By
Disease Indication
8.3.4.2.4.
By
End User
8.3.5.
Australia
Artificial Cornea and Corneal Implants Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By
Type
8.3.5.2.2.
By
Transplant Type
8.3.5.2.3.
By
Disease Indication
8.3.5.2.4.
By
End User
9.
South
America Artificial Cornea and Corneal Implants Market Outlook
9.1. Market Size & Forecast
9.1.1.
By
Value
9.2. Market Share & Forecast
9.2.1.
By
Type
9.2.2.
By
Transplant Type
9.2.3.
By
Disease Indication
9.2.4.
By
End User
9.2.5.
By
Country
9.3. South America: Country Analysis
9.3.1.
Brazil
Artificial Cornea and Corneal Implants Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By
Type
9.3.1.2.2.
By
Transplant Type
9.3.1.2.3.
By
Disease Indication
9.3.1.2.4.
By
End User
9.3.2.
Argentina
Artificial Cornea and Corneal Implants Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By
Type
9.3.2.2.2.
By
Transplant Type
9.3.2.2.3.
By
Disease Indication
9.3.2.2.4.
By
End User
9.3.3.
Colombia
Artificial Cornea and Corneal Implants Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By
Type
9.3.3.2.2.
By
Transplant Type
9.3.3.2.3.
By
Disease Indication
9.3.3.2.4.
By
End User
10. Middle East and Africa Artificial Cornea
and Corneal Implants Market Outlook
10.1.
Market
Size & Forecast
10.1.1. By Value
10.2.
Market
Share & Forecast
10.2.1. By Type
10.2.2. By Transplant Type
10.2.3. By Disease Indication
10.2.4. By End User
10.2.5. By Country
10.3.
MEA:
Country Analysis
10.3.1. South Africa Artificial Cornea and
Corneal Implants Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By
Type
10.3.1.2.2.
By
Transplant Type
10.3.1.2.3.
By
Disease Indication
10.3.1.2.4.
By
End User
10.3.2. Saudi Arabia Artificial Cornea and
Corneal Implants Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By
Type
10.3.2.2.2.
By
Transplant Type
10.3.2.2.3.
By
Disease Indication
10.3.2.2.4.
By
End User
10.3.3. UAE Artificial Cornea and Corneal
Implants Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By
Type
10.3.3.2.2.
By
Transplant Type
10.3.3.2.3.
By
Disease Indication
10.3.3.2.4.
By
End User
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Merger
& Acquisition (If Any)
12.2.
Product
Launches (If Any)
12.3.
Recent
Developments
13. Porter’s Five Forces Analysis
13.1.
Competition
in the Industry
13.2.
Potential
of New Entrants
13.3.
Power
of Suppliers
13.4.
Power
of Customers
13.5.
Threat
of Substitute Products
14. Competitive Landscape
14.1.
Regeneron Pharmaceuticals, Inc.
14.1.1. Business
Overview
14.1.2. Company
Snapshot
14.1.3. Products
& Services
14.1.4. Financials
(As Reported)
14.1.5. Recent
Developments
14.1.6. Key
Personnel Details
14.1.7. SWOT
Analysis
14.2.
Alcon, Inc.
14.3.
Bayer AG
14.4.
Bausch & Lomb Incorporated
14.5.
AJL Ophthalmic S.A.
14.6.
CorneaGen Inc.
14.7.
Addition Technology, Inc.
14.8.
LinkoCare Life Sciences AB
14.9.
Presbia plc
14.10.
EyeYon Medical Ltd.
15. Strategic Recommendations
16. About Us & Disclaimer